Department of Hematology

Hematology Home >

Faculty

Stephen M. Hahn

Henry K. Pancoast Professor of Radiation Oncology

Department: Radiation Oncology

Contact information

HUP
3400 SPRUCE ST.
4283
Philadelphia, PA 19104

Office: 2156627296

Email:
HAHN@XRT.UPENN.EDU

Education:
BA (Biology)
Rice University , 1980.
M.D. (?)
Temple University, 1984.

Certifications
American Board of Internal Medicine (Internal Medicine), 1988.
American Board of Radiology (Radiation Oncology), 1995.
American Board of Internal Medicine (Medical Oncology), 2002.

Permanent link

> School of Medicine > Faculty > Details

Selected Publications

Veronese, M., Stevenson, J.P., Sun, W., Redlinger, M., Algazy, K., Giantonio, B., Hahn, S., Vaughn, S., Thorn, C., Whitehead, A.S., Haller, D.G., and O’Dwyer, P.J. : Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer. Euro Journal of Cancer 2003.

Wilson, J.J., Jones, H., Burock, M., Smith, D., Fraker, D.L., Metz, J., Glatstein, E., and Hahn, S.M. : Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. International Journal of Oncology 2003.

Sun W, Stevenson JP, Gallagher ML, Vaughn D, Hahn SM, Haller DG, Cohen M, Kopit J, Gallant G, O'Dwyer PJ: Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 days. Clinical Cancer Research 9: 5221-52227, 2003.

Brunner, T.B., Hahn, S.M., Gupta, A.K., Muschel, R.J., McKenna, W.G., and Bernhard, E.J. : Farnesyltransferase inhibitors: An overview of the results of pre-clinical and clinical investigations. Cancer Research 79: 569-576, 2003.

DeGraff, W.G., Myers, L.S., Mitchell, J.B., and Hahn, S.M. : Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. International Journal of Oncology 23: 159-163, 2003.

Yom, S.S., Busch, T.M., Friedberg, J.S., Wileyto, E.P., Smith, D., Glatstein, E., and Hahn, S.M. : Elevated serum cytokine levels in mesothelioma patients treated with pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochemical Photobiology 78: 75-81, 2003.

Flaherty, K.T., Stevenson, J.P., Hahn, S.M., Redlinger, M., and O’Dwyer, P.J. : Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy. Cancer Chemother Pharmacol 52: 217-222, 2003.

Cheung, R., Solonenko, M., Busch, T.M., Del Piero, F., Putt, M.P., Hahn, S.M., and Yodh, A.G. : Correlation of in vivo photosensitizer fluorescence and photodynamic therapy induced depth of necrosis in a murine tumor model. J. Biomed Optics 8: 248-252, 2003.

Canter, R.J., Mick, R., Kesmodel, S.B., Raz, D.J., Spitz, F.R., Metz, J.M., Hahn, S.M., and Fraker, D.L. : Intraperitoneal Photodynamic Therapy (PDT) Causes a Capillary-Leak Syndrome. Ann Surg Onc 10: 514-524, 2003.

Colevas, A.D., Brown, J.M., Hahn, S., Mitchell, J., Camphausen, K., Coleman, C.N. for the National Cancer Institute Radiation Modifier Working Group. : Development of Investigational Radiation Modifiers. J Natl Cancer Inst 95(9): 646-651, 2003.